In PAD, tissue revascularization through exogenous application of angiogenic mitogens such as vascular endothelial growth factor (VEGF) and basic fibrobloast growth factor (bFGF) represents an interesting therapeutic approach [16]. This evidence concerns the gene VEGFA and peripheral arterial disease.